Aims & Scope:
Current Precision Medicine and Therapeutic Technologies focuses on publishing original research, reviews/mini-reviews and guest-edited thematic issues in all areas covering advancements in precision medicine and emerging therapeutic technologies. The journal emphasizes the integration of cutting-edge technologies such as artificial intelligence, multi-omics approaches, nanotechnology, and digital health tools to enable more accurate disease prediction, prevention, and personalized treatment. The journal welcomes articles in areas including, but not limited to:
- 3D bioprinting and tissue engineering
- Artificial intelligence in precision medicine
- Big data and health informatics in personalized care
- Biomarker discovery and validation
- Cell and gene therapies
- Clinical trials for individualized therapies
- Companion diagnostics
- Computational biology and systems medicine
- CRISPR and gene-editing technologies
- Ethical, regulatory, and policy aspects of precision medicine
- Genomic and molecular profiling
- Nanomedicine and targeted drug delivery
- Personalized drug therapy
- Pharmacogenomics and pharmacogenetics
- Precision medicine approaches and strategies
- Real-time patient monitoring tools
- RNA-based therapeutics (siRNA, mRNA, etc.)
- Targeted therapies and biologics
- Translational research and personalized healthcare systems
- Wearable and digital health technologies
Current Precision Medicine and Therapeutic Technologies is an international, peer-reviewed journal on all aspects of precision medicine and therapeutic technologies published continuously (print & online) by Bentham Science Publishers.
